| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2022-12-03 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $2.04M | $886.49K | $190.29K | $527.41K | – | $2.29M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $20.19M | $15.57M | $10.94M | $22.80M | – | $20.35M |
| R&D | $7.69M | $6.24M | $2.80M | $6.27M | – | $1.65M |
| SG&A | $12.42M | $9.15M | $7.88M | $14.68M | – | $15.95M |
| Operating Income | -$18.15M | -$14.68M | -$10.75M | -$22.27M | – | -$18.06M |
| Interest Expense | – | – | $1.11M | $1.36M | $696.00K | $585.64K |
| Tax Expense | – | – | $2.86K | $7.67K | – | $21.02K |
| Net Income | -$17.93M | -$14.28M | -$19.40M | -$24.23M | – | -$17.67M |
| EPS (basic) | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – |
| Shares (diluted) | $13.01M | $10.20M | $6.15M | $24.52M | – | $21.33M |